Longevity & AgingArticle de rechercheAccès payant

Mitochondria dock directly onto nuclear pores to fuel the cell nucleus

A Nature study finds VDAC1 on mitochondria binds RANBP2 at nuclear pores, supplying nuclear ATP and shaping cell differentiation and embryonic development.

samedi 24 octobre 2026 1 vue
Publié dans Nature
Glowing orange mitochondrion docked against a nuclear pore complex, VDAC channel binding filament proteins, ATP flowing into the nucleus

Résumé

Mitochondria are known to contact other organelles, such as the endoplasmic reticulum, but this study reveals a new partner: the nuclear pore complex. Using two unbiased proteomic screens (GST pulldown and BioID), researchers found that the mitochondrial channel protein VDAC1 interacts with RANBP2, a filament protein of the nuclear pore. Disrupting RANBP2 or the specific amino acids linking it to VDAC1 reduced mitochondria-nucleus proximity, lowered nuclear ATP and phosphocreatine, and decreased the nuclear phosphoproteome. Pathways for histone modification, differentiation, and transcriptional regulation were downregulated. In mice, deleting the RANBP2 C-terminal domain caused embryonic lethality with heart and neural crest defects. The findings suggest mitochondria directly supply energy to the nucleus, with implications for development and potentially aging biology. The work is preclinical and has no direct clinical application yet.

Résumé détaillé

Mitochondrial function declines with age, and mitochondria influence far more than energy production. They communicate with other organelles, including the endoplasmic reticulum, to regulate calcium and redox balance. How they supply and coordinate energy-dependent processes inside the nucleus, such as chromatin regulation and gene expression, has been less clear.

This study asked whether mitochondria physically interact with the nuclear pore complex. The researchers used two unbiased proteomic approaches, GST pulldown and BioID proximity labeling, to identify mitochondrial proteins that bind nuclear pore components. They then manipulated the interaction using RANBP2 CRISPR knockout, truncation, and site-directed mutagenesis in cells, and a C-terminal RANBP2 deletion in mice.

VDAC1, an outer mitochondrial membrane channel, emerged as the top mitochondrial candidate interacting with RANBP2, a filamentous protein on the nuclear pore. Disrupting this interaction reduced mitochondria-nucleus proximity and lowered nuclear ATP and phosphocreatine. The nuclear phosphoproteome declined, and pathways for histone modification, cellular differentiation, and transcriptional regulation were downregulated. In mice, losing the RANBP2 C-terminal domain caused embryonic lethality linked to cardiac and neural crest differentiation defects.

The work proposes a mechanism by which mitochondria directly support nuclear energetics and thereby cell fate decisions. For longevity research, it points to a possible link between mitochondrial health, nuclear energy supply, and epigenetic or transcriptional regulation, though this is a hypothesis for future testing.

Caveats: this summary is based only on the abstract. The data come from cell models and embryonic mouse development, not aging or human studies. Whether this interaction changes with age, or can be therapeutically targeted, remains unknown, and the authors note additional roles are yet to be discovered.

Principales conclusions

  • Two unbiased proteomic screens identified VDAC1 as the top mitochondrial protein interacting with the nuclear pore protein RANBP2.
  • Disrupting RANBP2-VDAC1 binding reduced mitochondria-nucleus proximity and lowered nuclear ATP and phosphocreatine levels.
  • Loss of the interaction decreased the nuclear phosphoproteome and downregulated histone modification and transcriptional regulation pathways.
  • Deleting the RANBP2 C-terminal domain in mice caused embryonic lethality with cardiac and neural crest differentiation defects.
  • Findings support a model in which mitochondria directly fuel nuclear energetics to regulate cell differentiation.

Méthodologie

Researchers combined GST pulldown and BioID proteomic screens to find mitochondrial-nuclear pore interactors, then used RANBP2 CRISPR knockout, truncation, and site-directed mutagenesis in vitro. Nuclear energetics and the phosphoproteome were measured, and a RANBP2 C-terminal domain deletion mouse model tested in vivo relevance.

Limites de l'étude

Analysis is based on the abstract only; details of effect sizes, models, and controls are unavailable. Evidence comes from cell systems and embryonic mouse development, with no aging, human, or therapeutic data. Whether this interaction changes with age or is druggable is untested, and the authors acknowledge further roles remain unknown.

Ce résumé vous a plu ?

Recevez les dernières recherches sur la longévité dans votre boîte de réception chaque semaine.

Saisissez votre e-mail pour vous abonner :